Plant exosome-like nano vesicle as well as preparation method and application thereof
Plant exosome-like nanovesicles prepared by enzymatic lysis and ultracentrifugation solve the complexity and stability of the extraction process, realize efficient and safe nanovesicles preparation, significantly improve intestinal mucosal barrier damage, Potential for the treatment of colitis.
Patent Information
- Application Number
- CN202411430102.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-14
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2044-10-14
AI Technical Summary
The prior art has problems such as complex operation, high cost, limited yield, environmental sensitivity and unstable delivery efficiency in the extraction and application of plant exosome-like nanovesicles, especially in improving intestinal mucosal barrier damage. Solution.
The exosome-like nanovesicles of prickly pear, maria saria seeds, mulberry leaves and gypsum were prepared by enzymatic lysis and multiple centrifugation. High-purity nanovesicles were obtained through enzymatic lysis and multiple centrifugation, and vacuum freeze-drying technology was used. Improve storage stability.
It realizes efficient extraction of plant exosome-like nanovesicles with simple operation, safe and environmentally friendly, significantly improves its biological activity and antioxidant properties, has good storage stability and digestive stability, can effectively improve intestinal mucosal barrier damage, and has Potential application value of colitis.
Smart Images

Figure CN119020256A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of biotechnology and life science technology, and in particular to a plant exosome-like nanovesicle and a preparation method and application thereof. Background Art
[0002] The intestine is the most important and critical digestive, absorptive and secretory organ in the human body. It is also the largest immune organ in the human body and the first line of defense against toxins and harmful substances. Its mucosal barrier can prevent harmful substances in the intestine, such as bacteria, toxins and food-borne antigens, from passing through the intestinal mucosa and entering other tissues, organs and blood circulation in the human body. Various reasons can lead to damage to the intestinal mucosal barrier function. When the intestinal barrier function is impaired, the intestinal mucosa atrophies and the intestinal permeability increases, which will lead to the displacement of intestinal bacteria and toxins, the release of a large number of pro-inflammatory factors, and the production of systemic inflammatory response syndrome, which further develops into multiple organ dysfunction, such as Crohn's disease, bacterial enteritis, alcoholic liver disease, fatty liver disease, pancreatitis, etc. Colitis is an inflammatory disease with a high incidence rate caused by impaired intestinal mucosal barrier function. The main clinical manifestations are diarrhea, abdominal pain, mucous stool and purulent stool, tenesmus, even constipation, and inability to defecate within a few days; often accompanied by weight loss and fatigue, and often recurring. As the incidence of colitis is gradually increasing, the course of the disease is long, and there is a risk of concurrent colon cancer, it has received more and more attention.
[0003] Extracellular vesicles (EVs) are lipid bilayer nanoparticles released from cells into the extracellular space, including exosomes, exosome-like nanoparticles, and outer membrane vesicles. EVs play an important role in the transport of biological molecules (such as proteins, lipids, etc.) and nucleic acids (including mRNA) in the human body. Due to its inherent biocompatibility, ability to cross physiological barriers, low immunogenicity, and targeted absorption by specific tissues, it has become a biological carrier with great potential. Plant exosome-like nanovesicles are nanoscale vesicles secreted by plant cells. They are widely available and contain rich bioactive substances. They play an outstanding role in intercellular communication and information transmission, maintaining homeostasis in organisms, and treating diseases. Studies have shown that plant exosome-like nanovesicles can protect the intestinal barrier and contribute to intestinal homeostasis by participating in intercellular communication containing DNA, mRNA, miRNA, proteins, lipids, and substances, improving the inflammatory response of intestinal cells, maintaining tight junction complexes, and regulating inflammatory responses.
[0004] Some herbal plants, such as roxburghii, wormwood, mulberry leaves, and gynostemma pentaphyllum, are rich in flavonoids, alkaloids, phytosterols, dietary fiber, and a variety of trace elements. They have high medicinal and health value and are often used for lowering blood lipids, anti-tumor, anti-inflammatory, and anti-oxidation. The exosome-like nanovesicles (ELNs) extracted from these plants not only have corresponding pharmacological effects, but also have the unique morphology and composition characteristics of nanocarriers. Studies have shown that plant exosome-like nanovesicles are absorbed by the intestine after reaching the small intestine through the vesicle transport mechanism, and are specifically phagocytosed by target cells, achieving anti-inflammatory, anti-oxidant, and mucosal repair effects, thereby achieving the effect of relieving inflammation. It has the function of maintaining intestinal homeostasis, and will not cause specific immune problems. It is expected to be used to prevent and treat colitis. This can be achieved through oral preparations, injections, and transdermal administration.
[0005] So far, ELNs derived from grapes, grapefruit, ginger, kudzu root and ginseng have been reported to be used to treat colitis due to their unique transport properties and biological functions. However, there are no relevant research reports on the application of ELNs derived from roxburghii, wormwood, mulberry leaves and Gynostemma pentaphyllum to improve intestinal mucosal barrier damage. Summary of the invention
[0006] In order to solve the above problems, the present invention provides a plant exosome-like nanovesicle and a preparation method and application thereof.
[0007] In a first aspect, the present invention provides a method for preparing plant exosome-like nanovesicles, the preparation method comprising the following steps:
[0008] The plant source and the buffer solution are mixed and crushed, and then enzymes are added for enzymolysis to obtain plant source juice;
[0009] Performing a first centrifugal separation on the plant-derived juice to obtain a supernatant;
[0010] The supernatant is subjected to a second centrifugal separation, and the obtained precipitate is then washed to obtain the plant exosome-like nanovesicles;
[0011] Wherein, the plant source includes at least one of roxburghii, wormwood seeds, mulberry leaves and gynostemma pentaphyllum.
[0012] Furthermore, the weight ratio of the plant source to the buffer is 2:1; the buffer comprises PBS buffer, and the pH of the PBS buffer is 6.0.
[0013] Furthermore, in terms of weight, the added amount of the enzyme accounts for 1 to 3 wt % of the total weight of the plant source and the buffer, and the enzyme includes cellulase.
[0014] Furthermore, the working condition parameters of the enzymatic hydrolysis include: an enzymatic hydrolysis temperature of 40 to 60° C. and an enzymatic hydrolysis time of 30 to 120 min.
[0015] Furthermore, the working condition parameters of the first centrifugal separation include: centrifugal force of 1200g to 10000g, centrifugal time of 20 to 100min, and centrifugal temperature of 4°C.
[0016] Furthermore, the step of subjecting the plant-derived juice to a first centrifugal separation to obtain a supernatant comprises the following process:
[0017] The plant-derived juice was centrifuged at 4° C. for 20 min at a centrifugal force of 1200 g, for 20 min at a centrifugal force of 3000 g, and for 60 min at a centrifugal force of 10000 g to obtain a supernatant.
[0018] Furthermore, the working condition parameters of the second centrifugal separation include: centrifugal force of 100000g, centrifugal time of 120min, and centrifugal temperature of 4°C.
[0019] Furthermore, the preparation method further comprises: vacuum freeze-drying the plant exosome-like nanovesicles to prepare freeze-dried powder.
[0020] In a second aspect, the present invention provides a plant exosome-like nanovesicle, wherein the plant exosome-like nanovesicle is prepared by the preparation method described in any one of the first aspects.
[0021] In a third aspect, the present invention provides the use of the plant exosome-like nanovesicles described in any one of the second aspects in the preparation of a product for improving intestinal mucosal barrier damage and repairing.
[0022] The above technical solution provided by the embodiment of the present invention has at least the following advantages compared with the prior art:
[0023] The embodiment of the present invention provides a method for preparing plant exosome-like nanovesicles. The present invention uses enzymatic hydrolysis combined with ultracentrifugation to successfully prepare roxburghii / artemisia seed / mulberry leaf / Gynostemma pentaphyllum ELNs, which has the characteristics of simple process, safety and environmental protection, and good biological activity of the obtained ELNs. At the same time, in-depth studies have shown that the obtained plant exosome-like nanovesicles are helpful in improving the repair of intestinal mucosal barrier damage, providing important data support for the development of intestinal mucosal barrier function restoration products. BRIEF DESCRIPTION OF THE DRAWINGS
[0024] The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments consistent with the invention and, together with the description, serve to explain the principles of the invention.
[0025] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, for ordinary technicians in this field, other drawings can be obtained based on these drawings without paying any creative labor.
[0026] Figure 1 A schematic diagram of a process for preparing plant exosome-like nanovesicles provided in an embodiment of the present invention.
[0027] Figure 2 This is the storage stability test result of the plant exosome-like nanovesicles obtained in Example 3 of the test example of the present invention at 4°C.
[0028] Figure 3 This is the storage stability test result of the plant exosome-like nanovesicles obtained in Example 3 of the test example of the present invention at a temperature of -20°C.
[0029] Figure 4 This is the antioxidant test result of the plant exosome-like nanovesicles obtained from Example 3 in the test example of the present invention under the FRAP method.
[0030] Figure 5 This is the antioxidant test result of the plant exosome-like nanovesicles obtained in Example 3 of the test example of the present invention under the DPPH method.
[0031] Figure 6 These are the digestion stability test results of the samples obtained in Example 3 of the test examples of the present invention in gastric juice and intestinal juice environments.
[0032] Figure 7 These are the test results of colon length and appearance characteristics of the samples obtained in Example 3 of the test examples of the present invention in an acute colitis mouse experiment.
[0033] Figure 8 This is the staining test result of colon tissue sections of the samples obtained in Example 3 of the test example of the present invention in an acute colitis mouse experiment.
[0034] Fig. 9 This is the test result of the inflammatory factor level in the serum of the sample obtained in Example 3 of the test example of the present invention in the acute colitis mouse experiment.
[0035] Fig.10 This is the test result of the level of intestinal tight junction protein in the serum of the sample obtained in Example 3 of the test example of the present invention in the acute colitis mouse experiment.
[0036] Fig.11 These are the in vivo fluorescence imaging and gastrointestinal imaging test results of the samples obtained in Example 3 of the test examples of the present invention.
[0037] Fig.12 This is a technical concept flow chart of the method for preparing plant exosome-like nanovesicles provided by the present invention. DETAILED DESCRIPTION
[0038] In order to make the purpose, technical solution and advantages of the embodiments of the present invention clearer, the technical solution in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0039] Unless otherwise specified, various raw materials, reagents, instruments and equipment used in the present invention can be purchased from the market or prepared by existing methods.
[0040] As an emerging bio-nanomaterial, plant exosome-like nanovesicles have shown extraordinary potential in the field of biomedicine, especially in drug delivery and disease treatment. However, the current separation and extraction technologies still face a series of challenges and shortcomings, such as complex operation and high cost, production restrictions, environmental sensitivity, unstable delivery efficiency, etc., as well as insufficient safety assessment of related products and lack of unified standards and specifications. Specifically:
[0041] (1) Complex operation and high cost: Existing extraction methods, such as ultracentrifugation combined with sucrose density gradient centrifugation, can effectively purify, but the operation is cumbersome, time-consuming, and has high requirements for equipment, which directly leads to high extraction costs and limits the possibility of large-scale commercial application.
[0042] (2) Production limitation: Current technology has not yet achieved efficient mass production of plant exosome-like nanovesicles. Although they can meet clinical and scientific research needs, they are subject to production limitations in their large-scale commercial production and application.
[0043] (3) Environmental sensitivity: The stability of plant exosome-like nanovesicles is easily affected by external environmental factors, such as temperature, pH value, storage conditions, etc., which may cause their biological activity to decrease or become inactivated. How to achieve long-term effective preservation while ensuring their biological activity is a difficult problem that we are currently facing and continue to overcome.
[0044] (4) Unstable delivery efficiency: The delivery efficiency of plant exosome-like nanovesicles in vivo is affected by many factors, such as blood circulation, tissue barriers, etc., and further modification or optimization is needed to achieve targeted delivery and improve delivery efficiency. In addition, plant exosome-like nanovesicles from different plant sources differ in composition and properties, and their extraction efficiency and purity are difficult to uniformly control.
[0045] For existing problems, such as Fig.12 As shown, the primary purpose of the present invention is to provide a method for preparing four kinds of plant-derived exosome-like nanovesicles, namely, roxburghii, wormwood seeds, mulberry leaves, and gynostemma pentaphyllum, which can quickly and efficiently obtain four kinds of plant-derived exosome-like nanovesicles. On the other hand: the present invention also provides the application of the above four kinds of plant-derived exosome-like nanovesicles in improving intestinal mucosal barrier damage, which provides important data support for the development of oral products and drugs for restoring intestinal mucosal barrier function. The technical scheme provided by the present invention is as follows:
[0046] In a first aspect, the present invention provides a method for preparing plant exosome-like nanovesicles, such as Figure 1 As shown, the preparation method comprises the following steps:
[0047] The plant source and the buffer solution are mixed and crushed, and then enzymes are added for enzymolysis to obtain plant source juice;
[0048] Performing a first centrifugal separation on the plant-derived juice to obtain a supernatant;
[0049] The supernatant is subjected to a second centrifugal separation, and the obtained precipitate is then washed to obtain the plant exosome-like nanovesicles;
[0050] Wherein, the plant source includes at least one of roxburghii, wormwood seeds, mulberry leaves and gynostemma pentaphyllum.
[0051] The embodiment of the present invention provides a method for preparing plant exosome-like nanovesicles. The present invention conducts in-depth research on the preparation methods of roxburghii, wormwood, mulberry leaves, and Gynostemma pentaphyllum ELNs and their applications in improving intestinal mucosal barrier damage. It is proved that the four plant exosome-like nanovesicles obtained by this method are helpful in improving the repair of intestinal mucosal barrier damage and have practical application value.
[0052] The present invention uses an enzymatic ultrafast method to prepare roxburghii / artemisia seed / mulberry leaf / Gynostemma pentaphyllum ELNs, which is not only simple in operation process, safe and environmentally friendly, but also effectively avoids the pollution and damage that may be caused by traditional extraction methods, and greatly improves the extraction rate and purity of plant exosome-like nanovesicles. The plant exosome-like nanovesicles prepared by this method are green and natural, have low immunogenicity, stable structure, and show good antioxidant properties and biological activity.
[0053] At the same time, the plant-derived exosome-like nanovesicles were freeze-dried using vacuum freeze-drying technology to obtain plant-derived exosome-like nanovesicle freeze-dried powder. The freeze-drying technology greatly improved the long-term storage stability of exosomes. The prepared sea buckthorn and mulberry leaf exosome-like nanovesicles have good storage stability, antioxidant activity and digestive stability, and the length of the mouse colon, the level of inflammatory factors in serum, and the level of intestinal tight junction proteins in serum have been improved to a certain extent, and are expected to be used to prevent and treat colitis.
[0054] In some specific embodiments, the weight ratio of the plant source to the buffer is 2:1; the buffer comprises a PBS buffer, and the pH of the PBS buffer is 6.0.
[0055] In some specific embodiments, the enzyme is added in an amount of 1 to 3 wt % of the total weight of the plant source and the buffer, and the enzyme comprises cellulase.
[0056] In some specific embodiments, the working condition parameters of the enzymatic hydrolysis include: an enzymatic hydrolysis temperature of 40 to 60° C. and an enzymatic hydrolysis time of 30 to 120 min.
[0057] In some specific embodiments, the working condition parameters of the first centrifugal separation include: centrifugal force of 1200g to 10000g, centrifugal time of 20 to 100 min, and centrifugal temperature of 4°C.
[0058] In some specific embodiments, the step of subjecting the plant-derived juice to a first centrifugal separation to obtain a supernatant comprises the following process:
[0059] The plant-derived juice was centrifuged at 4° C. for 20 min at a centrifugal force of 1200 g, for 20 min at a centrifugal force of 3000 g, and for 60 min at a centrifugal force of 10000 g to obtain a supernatant.
[0060] In some specific embodiments, the working condition parameters of the second centrifugal separation include: centrifugal force of 100000 g, centrifugal time of 120 min, and centrifugal temperature of 4°C.
[0061] In some specific embodiments, the preparation method further comprises: vacuum freeze-drying the plant exosome-like nanovesicles to prepare freeze-dried powder.
[0062] In some specific embodiments, the method for preparing plant exosome-like nanovesicles may specifically include:
[0063] Step 1, putting the roxburghii / artemisia seed / mulberry leaf / gynostemma pentaphyllum and PBS buffer into a crusher to crush and obtain the roxburghii / artemisia seed / mulberry leaf / gynostemma pentaphyllum juice, adding 2wt% of cellulase to the roxburghii / artemisia seed / mulberry leaf / gynostemma pentaphyllum juice in proportion at room temperature, and stirring and mixing;
[0064] Step 2, repeating the low-speed centrifugation of the liquid obtained in step 1 for several times, wherein the supernatant is taken after each centrifugation and centrifuged again;
[0065] Step 3: Repeat step 2 several times to obtain the supernatant by ultracentrifugation, take the precipitate, and resuspend it with PBS buffer to obtain roxburghii / artemisia seed / mulberry leaf / gynostemma pentaphyllum ELNs.
[0066] Step 4, vacuum freeze-drying the plant-derived exosome-like nanovesicles obtained in step 3 to obtain roxburghii / artemisia seed / mulberry leaf / gynostemma pentaphyllum ELNs freeze-dried powder;
[0067] The centrifugation temperature is 4°C, the centrifugation in step 2 is repeated 3 times, the first centrifugation condition is 1200g, 20min; the second centrifugation condition is 3000g, 20min; the third centrifugation condition is 10000g, 60min; the centrifugation condition has the best effect on removing large particles, fine fragments and some impurities; the ultracentrifugation condition in step 3 is 100000g, 120min; the purification effect is best under this centrifugation condition.
[0068] In a second aspect, based on the same inventive concept, the present invention provides a plant exosome-like nanovesicle, wherein the plant exosome-like nanovesicle is prepared by the preparation method described in any one of the first aspects.
[0069] It should be noted that the various components involved in the plant exosome-like nanovesicles and the preparation method thereof provided in the embodiments of the present invention, unless otherwise specified or specifically described, can all be commercially available products; at the same time, the steps and parameters involved in the preparation method, unless otherwise specified or specifically described, can all be carried out according to existing processes.
[0070] In the third aspect, based on the same inventive concept, the present invention provides the use of the plant exosome-like nanovesicles described in any one of the second aspects in the preparation of a product for improving intestinal mucosal barrier damage and repairing.
[0071] In summary, the present invention provides four methods for preparing exosome-like nanovesicles derived from plants for use in mucosal barrier repair. Compared with the prior art, the present invention has the following advantages:
[0072] (1) The present invention successfully prepared ROSA ROSA / ARTEMIS SANDO SEED / MULBERRY LEAF / Gynostemma ELNs by using enzymatic hydrolysis combined with ultracentrifugation. This method has a simple operation process, is safe and environmentally friendly, and effectively avoids the pollution and damage that may be caused by traditional extraction methods, greatly improving the extraction rate and purity of plant exosome-like nanovesicles. The ELNs prepared by this method are green, natural and low in immunogenicity, have a stable structure, and exhibit good antioxidant properties and biological activity.
[0073] (2) In addition, as natural nanoformulations, the above four plant exosome-like nanovesicles have the morphology and characteristics of nanocarriers and can be used as low-toxic nanocarriers to achieve targeted delivery of functional biomacromolecules (such as nucleic acids, therapeutic proteins, etc.). They are also superior to other nanocarriers in terms of in vivo distribution and stability, which is beneficial for prolonging their effective action time in vivo. They are rich in bioactive lipids, proteins, RNA and other components, which can directly act on damaged mucosal cells and promote cell repair and regeneration. In mucosal barrier repair, this means that they can carry therapeutic substances precisely to the damaged mucosal site, improve the treatment effect and reduce the potential impact on other healthy tissues.
[0074] (3) The plant exosome-like nanovesicle freeze-dried powder prepared by the present invention has a fluffy appearance, a compact powder texture, can be quickly re-dissolved, and the solution is clear and transparent after re-dissolution. The properties such as the particle size and morphology of the plant exosome-like nanovesicles after re-dissolution do not change significantly, which is of great value to the long-term stability of exosomes.
[0075] The present invention will be further described below in conjunction with specific examples. It should be understood that these examples are intended only to illustrate the present invention and are not intended to limit the scope of the present invention. The experimental methods in the following examples that do not specify specific conditions are usually measured according to national standards. If there is no corresponding national standard, then the conditions recommended by the manufacturer are followed.
[0076] Example 1
[0077] This example provides a plant exosome-like nanovesicle and a preparation method thereof, the preparation method comprising the following steps:
[0078] (1) putting clean plant-based roxburghii and pH 6.0 PBS buffer into a crusher at a weight ratio of 2:1 to obtain plant-based juice;
[0079] (2) Repeat low-speed centrifugation of the plant-derived juice obtained in step 1 for several times at 4° C., and centrifuge the supernatant again; wherein the process is repeated 3 times, and the centrifugation conditions for the 3 times are 1200 g, 20 min; 3000 g, 20 min; and 10000 g, 60 min, respectively;
[0080] (3) Repeat step 2 for three times at 4°C to obtain the supernatant, ultracentrifuge at 100,000 g for 120 min, collect the precipitate, wash it three times with PBS buffer, resuspend it to obtain the roxburghii ELNs, and place it in a -80°C refrigerator for later use;
[0081] (4) The plant-derived exosome-like nanovesicles obtained in step 3 are vacuum freeze-dried. The working condition parameters of the vacuum freeze-drying include: a vacuum degree of 41.3 Pa, a freezing temperature of 56.6° C., and a freezing time of 48 h, to obtain a freeze-dried powder.
[0082] Based on the preparation of Rosa roxburghii exosome-like nanovesicles using Rosa roxburghii as the plant source in the above Example 1, Artemisia ordosica seed exosome-like nanovesicles, mulberry leaf exosome-like nanovesicles and Gynostemma pentaphyllum exosome-like nanovesicles were prepared using Artemisia ordosica seed, mulberry leaf and Gynostemma pentaphyllum as the plant sources, respectively.
[0083] Example 2
[0084] This example provides a plant exosome-like nanovesicle and a preparation method thereof, the preparation method comprising the following steps:
[0085] (1) putting clean plant-derived roxburghii and pH 6.0 PBS buffer into a crusher at a weight ratio of 2:1, then adding 1% cellulase in proportion at room temperature, stirring evenly, and obtaining plant-derived juice;
[0086] (2) Repeat low-speed centrifugation of the plant-derived juice obtained in step 1 for several times at 4° C., and centrifuge the supernatant again; wherein the process is repeated 3 times, and the centrifugation conditions for the 3 times are 1200 g, 20 min; 3000 g, 20 min; and 10000 g, 60 min, respectively;
[0087] (3) Repeat step 2 for three times at 4°C to obtain the supernatant, ultracentrifuge at 100,000 g for 120 min, collect the precipitate, wash it three times with PBS buffer, resuspend it to obtain the roxburghii ELNs, and place it in a -80°C refrigerator for later use;
[0088] (4) The plant-derived exosome-like nanovesicles obtained in step 3 are vacuum freeze-dried. The working condition parameters of the vacuum freeze-drying include: a vacuum degree of 41.3 Pa, a freezing temperature of 56.6° C., and a freezing time of 48 h, to obtain a freeze-dried powder.
[0089] Based on the preparation of Rosa roxburghii exosome-like nanovesicle freeze-dried powder using Rosa roxburghii as the plant source in the above Example 2, Artemisia sphaerocephala seeds, mulberry leaves, and Gynostemma pentaphyllum were used as plant sources to prepare Artemisia sphaerocephala seeds exosome-like nanovesicle freeze-dried powder, mulberry leaf exosome-like nanovesicle freeze-dried powder, and Gynostemma pentaphyllum exosome-like nanovesicle freeze-dried powder, respectively.
[0090] Example 3
[0091] This example provides a plant exosome-like nanovesicle and a preparation method thereof, the preparation method comprising the following steps:
[0092] (1) putting clean plant-derived roxburghii and pH 6.0 PBS buffer into a crusher at a weight ratio of 2:1, then adding 2% cellulase in proportion at room temperature, stirring evenly, and obtaining plant-derived juice;
[0093] (2) Repeat low-speed centrifugation of the plant-derived juice obtained in step 1 for several times at 4° C., and centrifuge the supernatant again; wherein the process is repeated 3 times, and the centrifugation conditions for the 3 times are 1200 g, 20 min; 3000 g, 20 min; and 10000 g, 60 min, respectively;
[0094] (3) Repeat step 2 for three times at 4°C to obtain the supernatant, ultracentrifuge at 100,000 g for 120 min, collect the precipitate, wash it three times with PBS buffer, resuspend it to obtain the roxburghii ELNs, and place it in a -80°C refrigerator for later use;
[0095] (4) The plant-derived exosome-like nanovesicles obtained in step 3 are vacuum freeze-dried. The working condition parameters of the vacuum freeze-drying include: a vacuum degree of 41.3 Pa, a freezing temperature of 56.6° C., and a freezing time of 48 h, to obtain a freeze-dried powder.
[0096] Based on the preparation of Rosa roxburghii exosome-like nanovesicle freeze-dried powder using Rosa roxburghii as the plant source in the above Example 3, Artemisia sphaerocephala seeds, mulberry leaves, and Gynostemma pentaphyllum were used as plant sources to prepare Artemisia sphaerocephala seeds exosome-like nanovesicle freeze-dried powder, mulberry leaf exosome-like nanovesicle freeze-dried powder, and Gynostemma pentaphyllum exosome-like nanovesicle freeze-dried powder, respectively.
[0097] Example 4
[0098] This example provides a plant exosome-like nanovesicle and a preparation method thereof, the preparation method comprising the following steps:
[0099] (1) putting clean plant-derived roxburghii and pH 6.0 PBS buffer into a crusher at a weight ratio of 2:1, then adding 3% cellulase in proportion at room temperature, stirring evenly, and obtaining plant-derived juice;
[0100] (2) Repeat low-speed centrifugation of the plant-derived juice obtained in step 1 for several times at 4° C., and centrifuge the supernatant again; wherein the process is repeated 3 times, and the centrifugation conditions for the 3 times are 1200 g, 20 min; 3000 g, 20 min; and 10000 g, 60 min, respectively;
[0101] (3) Repeat step 2 for three times at 4°C to obtain the supernatant, ultracentrifuge at 100,000 g for 120 min, collect the precipitate, wash it three times with PBS buffer, resuspend it to obtain the roxburghii ELNs, and place it in a -80°C refrigerator for later use;
[0102] (4) The plant-derived exosome-like nanovesicles obtained in step 3 are vacuum freeze-dried. The working condition parameters of the vacuum freeze-drying include: a vacuum degree of 41.3 Pa, a freezing temperature of 56.6° C., and a freezing time of 48 h, to obtain a freeze-dried powder.
[0103] Based on the preparation of Rosa roxburghii exosome-like nanovesicle freeze-dried powder using Rosa roxburghii as the plant source in the above-mentioned Example 4, Artemisia sphaerocephala seeds, mulberry leaves, and Gynostemma pentaphyllum were used as plant sources to prepare Artemisia sphaerocephala seeds exosome-like nanovesicle freeze-dried powder, mulberry leaf exosome-like nanovesicle freeze-dried powder, and Gynostemma pentaphyllum exosome-like nanovesicle freeze-dried powder, respectively.
[0104] Taking the roxburghii exosome-like nanovesicles as an example, the BCA protein quantification kit (Biyuntian Biotechnology Co., Ltd.) was used to measure the protein concentration of the roxburghii exosome-like nanovesicles obtained in the above example. The test results of the exosome-like nanovesicles in the above example are shown in Table 1 below.
[0105] Table 1
[0106]
[0107] Example 5
[0108] On the basis of the above-mentioned Example 4, taking the roxburghii exosome-like nanovesicles as an example, the single factor variable method (that is, only a key condition parameter in Example 4 is adjusted, and the other steps and conditions are the same as Example 4) is adopted to screen the reaction condition parameters in each preparation step in Example 4. The specific condition parameters of each single variable and the protein concentration and extraction rate in the obtained roxburghii exosome-like nanovesicles are shown in Table 2.
[0109] Table 2
[0110]
[0111] Test Case
[0112] The four plant exosome-like nanovesicles obtained in Example 3 were taken out in appropriate amounts and diluted to an appropriate concentration using PBS buffer. In this example, the performance of the four samples of Rosa roxburghii / Artemisia sphaerocephala seeds / mulberry leaves / Gynostemma pentaphyllum exosome-like nanovesicles obtained in Example 3 were tested and analyzed.
[0113] 1. Characterization and analysis of exosome-like nanovesicles
[0114] (1) Storage stability
[0115] Appropriate amounts of exosome-like nanovesicles from roxburghii / artemisia sphaerocephala seeds / mulberry leaves / Gynostemma pentaphyllum were taken, diluted with PBS buffer and dispensed into test tubes, which were stored at 4°C and -20°C for 12 days, respectively. The particle size of each sample was measured regularly (0, 4, 8, 12 days) using a NanoZS90 particle size analyzer in automatic mode to evaluate its storage stability. Figure 2 and Figure 3 As shown in Figure 2, the particle sizes of the four freshly prepared exosome-like nanovesicles were not much different, all less than 200 nm. Further storage observations revealed that at 4°C ( Figure 2 ) storage conditions, the particle size of the four nanovesicles showed a trend of increasing to varying degrees over time, indicating that their stability gradually decreased. In contrast, at -20℃ ( Figure 3 ) storage, the size increase of the four exosome-like nanovesicles showed a significant slowing trend. Figure 3 ) storage conditions, within 8 days, the particle size remained basically stable, reflecting high storage stability. As the storage time was extended to 12 days, a significant trend of increasing particle size began to appear. In summary, the four exosome-like nanovesicles can maintain good storage stability for at least 8 days when stored at -20°C.
[0116] (2) Antioxidant properties
[0117] The FRAP (ferric ion reducing ability) method and DPPH (1,1-diphenyl-2-trinitrophenylhydrazine) method were used to evaluate the antioxidant properties of exosome-like nanovesicles from four different sources, such as Figure 4 and Figure 5 As shown. It can be seen that the FRAP values and DPPH clearance rates of exosome-like nanovesicles from four different sources all show a significant upward trend with the increase of protein concentration. The larger the FRAP value and DPPH clearance rate, the stronger its antioxidant activity. Specifically, at the same protein concentration, Gynostemma pentaphyllum exosome-like nanovesicles have the highest FRAP value and DPPH clearance rate, and have the strongest antioxidant activity, followed by mulberry leaves, roxburghii, and wormwood seeds.
[0118] (3) Digestion stability
[0119] First, simulated gastric fluid (SGF) and intestinal fluid (SIF) were prepared. Subsequently, PBS buffer was used to dilute the sea buckthorn / artemisia seed / mulberry leaf / Gynostemma pentaphyllum ELNs, respectively. Next, 0.5 mL of each diluted liquid was added to 5 mL of pre-prepared simulated gastric fluid. In a 37°C constant temperature shaker, let it stand for 2 hours. After the predetermined time, 1.5 mL was taken out from each group of samples, and the particle size distribution was immediately determined to evaluate its stability in the simulated gastric environment. After completing the simulated gastric digestion stage, the simulated gastric fluid of each group was replaced with simulated intestinal fluid to continue the simulation of the intestinal digestion process. The samples were placed in a 37°C constant temperature shaker again and let stand for 2 hours. After the time was up, 1.5 mL was taken out from each group of samples, and the particle size distribution was immediately determined. As Figure 6 As shown in the figure, through this series of in vitro simulated digestion experiments, it can be clearly observed that the particle size of the roxburghii / artemisia seed / mulberry leaf / Gynostemma pentaphyllum ELNs did not change significantly after simulated digestion in the stomach and intestines. This result shows that the roxburghii / artemisia seed / mulberry leaf / Gynostemma pentaphyllum ELNs exhibit good stability in the gastrointestinal environment, providing strong support for their application as a potential drug delivery system or functional food ingredient.
[0120] 2. Acute colitis mouse experiment
[0121] (1) Establishment and grouping of acute colitis mouse model
[0122] Before the experiment, 42 6-8 weeks old SPF Balb / c mice were adaptively fed for one week and randomly divided into 6 groups (n=7 in each group): blank control group (Control), model group (DSS), Rosa roxburghii exosome-like nanovesicles (DSS+R-ELNs), Artemisia sphaerocephala seed exosome-like nanovesicles (DSS+A-ELNs), mulberry leaf exosome-like nanovesicles (DSS+M-ELNs) and Gynostemma pentaphyllum exosome-like nanovesicles (DSS+G-ELNs). The 6 groups did not receive any treatment in terms of diet. Except for the control group, 3% DSS was added to the drinking water of the other 5 groups to induce colitis in mice. The four plant exosome-like nanovesicle groups were intragastrically administered once a day at a dose of 10 mg / kg for 14 consecutive days; all mice were killed 24 hours after administration on the 14th day.
[0123] (2) Colon length and appearance characteristics
[0124] The mice were killed 24 hours after administration on the 14th day. During the experiment, the mice showed obvious symptoms of colitis, such as weight loss, loose stools, and bloody stools. Figure 7As shown in the figure, by observing the macroscopic state of the colon, it was found that the colon of the DSS group mice was significantly shortened compared with the normal mouse group. After treatment with Rosa roxburghii / Artemisia sphaerocephala seeds / mulberry leaves / Gynostemma pentaphyllum ELNs, the shortening of the colon of the mice was improved, and the colon length increased slightly. Among them, the DSS+M-ELNs and DSS+G-ELNs groups were closer to the normal state.
[0125] (3) Colon tissue section staining
[0126] Histopathological analysis showed that ( Figure 8 ), the normal group had intact colonic tissue mucosa and crypts, thin submucosal layer and peripheral muscle layer, no inflammatory infiltration, and no obvious pathological changes. The DSS group had severe crypt destruction and inflammatory cell infiltration. After treatment with the four types of PELNs, all of them were improved, with an increase in the number of crypts, a more complete structure, and reduced edema and inflammatory cell infiltration. In addition, the roxburghii ELNs and mulberry leaf ELNs groups significantly improved and reduced colon histological scores compared with the other two groups.
[0127] (4) Levels of inflammatory factors in serum
[0128] like Fig. 9 As shown in the results, compared with the control group, the levels of IL-1β, IL-6 and TNF-α in the serum of mice induced by DSS were significantly increased. The ELNs groups were able to effectively reduce the levels of various inflammatory factors, especially the Rosa roxburghii ELNs and mulberry leaf ELNs groups.
[0129] (5) Serum levels of intestinal tight junction proteins
[0130] Tight junctions are the main determinant of intestinal barrier function to maintain mucosal permeability, among which Claudin-1, ZO-1 and Occludin play an important role and are widely used as markers of intestinal integrity. Fig.10 As shown in the data, compared with the control group, the TJ proteins (Claudin-1, ZO-1 and Occludin) induced by DSS decreased significantly, the TJ protein levels in the four PELNs groups were significantly higher than those in the DSS group, and the levels in the Rosa roxburghii ELNs and mulberry leaf ELNs groups were more significant than those in the other sample groups.
[0131] (6) In vivo fluorescence imaging and gastrointestinal imaging
[0132] Cy5.5 labeled exosome-like nanovesicles: Add 10 mM Cy5.5 dye to 2 mg / mL plant exosome-like nanovesicles and incubate with gentle shaking for 60 min at room temperature. The above experiments were carried out in the dark.
[0133] In vivo fluorescence imaging: C57BL / 6 mice were gavaged with 200uL / mouse of Cy5.5-labeled plant exosome-like nanovesicles, and the mice were anesthetized at 0.5, 1, 2, 4, 6, 8, and 10 hours for in vivo imaging.
[0134] Gastrointestinal imaging: The mice were killed and the gastrointestinal part was taken out for imaging. In order to further study the distribution of plant exosome-like nanovesicles in the gastrointestinal tract, in vitro fluorescence imaging of the gastrointestinal tissue of mice was performed at 0.5, 1, 2, 4, 6, 8, and 10 h.
[0135] like Fig.11 As shown, in in vivo fluorescence imaging, a clear fluorescence signal was detected in the upper abdomen of the mouse 0.5 h after oral administration, and then gradually spread to the lower abdomen. After 10 h, the in vivo fluorescence signal was very weak. In gastrointestinal imaging, at 0.5 h, plant exosome-like nanovesicles covered the stomach, duodenum, and jejunum, and at 2 h they were mainly in the ileum. After 4 h, there was almost no fluorescence signal in the upper half of the intestine, and there was a strong fluorescence signal in the cecum and colon. After 8 h, the fluorescence signal of the entire intestine decreased sharply, and at 10 h only part of the stomach and the end of the intestine had residual fluorescence, indicating that most of the plant exosome-like nanovesicles were metabolized.
[0136] Various embodiments of the present invention may be presented in the form of a range; it should be understood that the description in the form of a range is only for convenience and brevity, and should not be understood as a rigid limitation on the scope of the present invention; therefore, the range description should be considered to have specifically disclosed all possible sub-ranges and single numerical values within the range. For example, the range description from 1 to 6 should be considered to have specifically disclosed sub-ranges, such as from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2 to 6, from 3 to 6, etc., as well as single numbers within the range, such as 1, 2, 3, 4, 5 and 6, which apply regardless of the range. In addition, whenever a numerical range is indicated herein, it is meant to include any cited number (fractional or integer) within the indicated range.
[0137] The foregoing is merely a specific embodiment of the present invention, which enables those skilled in the art to understand or implement the present invention. Various modifications to these embodiments will be apparent to those skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the present invention. Therefore, the present invention will not be limited to the embodiments shown herein, but rather to the widest scope consistent with the principles and novel features claimed herein.
Claims
1. A method for preparing plant exosome-like nanovesicles, characterized in that: The preparation method comprises the following steps: The plant source and the buffer solution are mixed and crushed, and then enzymes are added for enzymolysis to obtain plant source juice; Performing a first centrifugal separation on the plant-derived juice to obtain a supernatant; The supernatant is subjected to a second centrifugal separation, and the obtained precipitate is then washed to obtain the plant exosome-like nanovesicles; Wherein, the plant source includes at least one of roxburghii, wormwood seeds, mulberry leaves and gynostemma pentaphyllum.
2. The method for preparing plant exosome-like nanovesicles according to claim 1, characterized in that: The weight ratio of the plant source to the buffer is 2:1; the buffer comprises a PBS buffer, and the pH of the PBS buffer is 6.
0.
3. The method for preparing plant exosome-like nanovesicles according to claim 1, characterized in that: In terms of weight, the added amount of the enzyme accounts for 1-3 wt% of the total weight of the plant source and the buffer solution, and the enzyme includes cellulase.
4. The method for preparing plant exosome-like nanovesicles according to claim 1, characterized in that: The working condition parameters of the enzymatic hydrolysis include: the enzymatic hydrolysis temperature is 40-60° C., and the enzymatic hydrolysis time is 30-120 min.
5. The method for preparing plant exosome-like nanovesicles according to claim 1, characterized in that: The working condition parameters of the first centrifugal separation include: centrifugal force of 1200g to 10000g, centrifugal time of 20 to 100min, and centrifugal temperature of 4°C.
6. The method for preparing plant exosome-like nanovesicles according to claim 1, characterized in that: The step of subjecting the plant-derived juice to a first centrifugal separation to obtain a supernatant comprises the following process: The plant-derived juice was centrifuged at 4° C. for 20 min at a centrifugal force of 1200 g, for 20 min at a centrifugal force of 3000 g, and for 60 min at a centrifugal force of 10000 g to obtain a supernatant.
7. The method for preparing plant exosome-like nanovesicles according to claim 1, characterized in that: The working condition parameters of the second centrifugal separation include: centrifugal force of 100000g, centrifugal time of 120min, and centrifugal temperature of 4°C.
8. The method for preparing plant exosome-like nanovesicles according to any one of claims 1 to 7, characterized in that: The preparation method further comprises: vacuum freeze-drying the plant exosome-like nanovesicles to prepare freeze-dried powder.
9. A plant exosome-like nanovesicle, characterized in that: The plant exosome-like nanovesicles are prepared by the preparation method described in any one of claims 1 to 8.
10. Use of the plant exosome-like nanovesicles according to claim 9 in the preparation of a product for improving and repairing intestinal mucosal barrier damage.
Citation Information
Patent Citations
Anti-colitis extract prepared on basis of roxburgh rose pomace as well as preparation method and application thereof
CN112656852A
Plant exosome, preparation method and application of plant exosome in anti-skin aging products
CN115584337A
Preparation method of plant extracellular vesicles
CN117050926A
Functional beverage containing bioactive small molecules and raw material preparation method
CN117256758A
Preparation method and application of engineered plant exosome for improving mitochondrial dysfunction
CN117363557A
Cited By
Bulbophyte extracellular vesicle as well as preparation method and application thereof
CN119220481A
Preparation method of plant-derived nano-vesicle and plant-derived nano-vesicle
CN121674321A
Method for isolating microvesicules from plants of the Amaranthaceae family
US12514891B2
